Launch and Improvement of Products with Safety Mechanisms and New Catheter Products

「During the fiscal year, the company added 4.5F and 5F Parent Select products for the radial approach to its lineup and began sales, with the aim of providing less-invasive treatment. …It obtained manufacturing and marketing approval for the product marketed as Medikit Occlusion Balloon Catheter 2 (nickname: CANDIS) and began sales. …It obtained manufacturing and marketing approval for the product marketed as Medikit Super Sheath II (nickname: VARIUS) and began sales.」

「In Japan, the company worked to promote sales and adoption of Happycass ProFlex, a dialysis indwelling needle with a built-in hemostatic valve and a needlestick-prevention mechanism, and Supercath 5 and Supercath 7, among others, in the hemodialysis and venous indwelling needle categories, respectively. In the intervention category, it worked to expand sales of Super Sheath Coat Plus, AbRoad STOUT, a braided sheath for arrhythmia treatment, and AbRoad FLEX, a steerable sheath.」

「Medilizer AGD System, a cerebrovascular guide-assist device developed by Bolt Medical Co., Ltd., which the company acquired in December 2022 and for which domestic manufacturing and marketing approval was obtained in June 2024, was listed for reimbursement and launched for sale on 1 March 2025.」

「In Japan, the company worked to promote sales and adoption of Happycass ProFlex, a dialysis indwelling needle with a built-in hemostatic valve and a needlestick-prevention mechanism, and Supercath 5 and Supercath 7, among others, in the hemodialysis and venous indwelling needle categories, respectively. In the intervention category, it worked to expand sales of Super Sheath Coat Plus, AbRoad STOUT, a braided sheath for arrhythmia treatment, and AbRoad FLEX, a steerable sheath.」

「In Japan, the company worked to promote sales and adoption of Happycass ProFlex, a dialysis indwelling needle with a built-in hemostatic valve and a needlestick-prevention mechanism, and Supercath 5 and Supercath 7, among others, in the hemodialysis and venous indwelling needle categories, respectively. In the intervention category, it worked to expand sales of Super Sheath Coat Plus, AbRoad STOUT, a braided sheath for arrhythmia treatment, and AbRoad FLEX, a steerable sheath.」

「Specifically, in Japan, the company worked to promote sales and adoption of Happycass ProFlex, a dialysis indwelling needle with a built-in hemostatic valve and a needlestick-prevention mechanism, and Supercath 5 and Supercath 7, among others, in the hemodialysis and venous indwelling needle categories, respectively. In the intervention category, it worked to expand sales of Super Sheath Coat Plus, AbRoad STOUT, a braided sheath for arrhythmia treatment, and AbRoad FLEX, a steerable sheath.」

「In Japan, the company continued promoting sales and adoption of Happycass ProFlex, a dialysis indwelling needle with a built-in hemostatic valve and a needlestick-prevention mechanism, in the hemodialysis category, and Supercath 7, a venous indwelling needle with a passive needlestick-prevention mechanism. In the intervention category, despite the impact of the termination of the domestic sales agreement for a device used to treat calcified lesions, the company worked to strengthen sales of Super Sheath Coat Plus, which improves Super Sheath functionality, AbRoad STOUT, a braided sheath for arrhythmia treatment, and AbRoad FLEX, a steerable sheath.」

「In terms of sales, the company worked to expand sales and adoption of Happycass ProFlex, a dialysis indwelling needle, and Supercath 7, a venous indwelling needle. In the intervention category, it introduced Super Sheath Coat Plus, an improved version of an existing product, and launched AbRoad STOUT, a braided sheath for arrhythmia treatment, and AbRoad FLEX, a steerable sheath.」

「In terms of sales, the company worked to expand sales and adoption of Supercath 7, a venous indwelling needle launched the previous year, and Happycass ProFlex, a dialysis indwelling needle launched the previous year. In the intervention category, it introduced Super Sheath Coat Plus, an improved version of an existing product, and launched AbRoad STOUT, a braided sheath for arrhythmia treatment, and AbRoad FLEX, a steerable sheath.」

「In terms of sales, the company worked to expand sales and adoption of Supercath 7, a venous indwelling needle launched the previous year, and Happycass ProFlex, a dialysis indwelling needle launched the previous year, while promoting sales by introducing improved versions of existing products in the intervention category.」

「In fiscal 2021, the company modified the outer needle of Happycass NEO, its safety-mechanism-equipped dialysis indwelling needle, and began selling Happycass ProFlex, which incorporates a hemostatic valve. …During the fiscal year, the company began full-scale sales of Supercath 7, a venous indwelling needle with a passive needlestick-prevention mechanism. …In fiscal 2021, the company began selling the Medikit Exchange Device (nickname: EZ-Keeper) as a catheter for exchanging coronary catheters. …The company has begun selling Parent select5082. …Manufacturing and marketing approval was obtained.」

「In terms of sales, the company worked to promote sales, including the launch in April of Supercath 7, an indwelling needle with a passive needlestick-prevention mechanism, in the venous indwelling needle category, and the launch in July of Happycass Pro Flex, a dialysis indwelling needle with a built-in hemostatic valve and a needlestick-prevention mechanism, in the hemodialysis category.」

「In terms of sales, the company worked to promote sales, including the launch in April 2021 of Supercath 7, an indwelling needle with a passive needlestick-prevention mechanism, in the venous indwelling needle category, and the launch in July 2021 of Happycass Pro Flex, a dialysis indwelling needle with a built-in hemostatic valve and a needlestick-prevention mechanism, in the hemodialysis category.」

「In terms of sales, the company worked to promote sales of venous indwelling needles, including the launch of Supercath 7, an indwelling needle with a passive needlestick-prevention mechanism, in April 2021.」

「In fiscal 2020, the company modified the outer needle of Happycass C-Pro, a dialysis catheter equipped with its safety mechanism, and continued developing Happycass ProFlex, which incorporates a hemostatic valve. The company aims to begin full-scale sales in the following fiscal year.」

「During the fiscal year, the company began selling Supercath 7, a passive-type peripheral intravenous catheter with a needlestick-prevention mechanism, at some facilities. The concept is to automatically cover the needle tip when the inner needle is removed, minimizing the risk of blood splatter. From the following fiscal year, the company will step up sales efforts at facilities requiring passive-type safety mechanisms.」

「The company launched the improved Happycass EBC-Pro, with further enhanced hemostatic-valve performance and patient safety as a key consideration. It also launched Happycass EBC-Pro with syringe, which adds a syringe and a passive safety mechanism.」

「The company launched Happycass EBC-Pro, which features improved hemostatic-valve performance and a change in sterilization method from ethylene oxide gas sterilization to electron-beam sterilization, taking patient safety into consideration to the greatest extent possible. It also launched Happycass EB Z1RP, a product with a syringe incorporating the same outer needle, which likewise uses electron-beam sterilization. The company is currently conducting verification work toward the launch of Happycass EBC-Pro with syringe, a product that adds a passive safety mechanism to the syringe-equipped product. It also launched Katchin-kun, a hemostasis device that assists patients with hemostasis after dialysis treatment.」

「In fiscal 2015, the company launched Happycass C-Pro, which combines the valve-equipped outer needle incorporated in Happycass C, enabling reliable and repeated hemostasis, with the passive safety mechanism incorporated in Happycass NEO, which minimizes blood exposure and stores the inner needle simultaneously with its removal.」